Datasea Enters into New Sales Agreements for its 5G AI Communications and High Tech Acoustic Segments Expecting $62 Million in Sales
The Three Agreements Support Continued Fiscal Year 2025 Revenue Growth for its Core AI-Based Businesses BEIJING, July 1, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a Nevada corporation engaged in innovative businesses in high-tech intelligent acoustics and 5G-Artificial Intelligence ("AI") multimodal communication technology in the United States and...
Noul Co., Ltd. Releases 2023-2024 Sustainability Report
CEO David Lim: "Committed to achieving genuine ESG practices and outstanding business performance simultaneously" First KOSDAQ-listed medical AI company to publish a sustainability report Reflecting a commitment to AI technology for social impact and social responsibility YONGIN, South Korea, July 1, 2024 /PRNewswire/ -- Noul Co., Ltd. (CEO: David Lim) has...
JCI Publishes 8th Edition of International Accreditation Standards for Hospitals and Academic Medical Centers
8th edition strengthens existing standards to advance patient safety and quality improvement OAKBROOK TERRACE, Ill., July 1, 2024 /PRNewswire/ -- Joint Commission International (JCI) has released the 8th edition of its Accreditation Standards for Hospitals and Academic Medical Centers. These evidence-based standards define the performance expectations, structures and functions necessary for hospitals...
HistoIndex Charts New Course in Liver Disease Innovation: Announces Pivotal Changes to Scientific Advisory Board
Company to appoint Prof. Arun J. Sanyal as the new Chairman of HistoIndex's Scientific Advisory Board, bringing unparalleled expertise to guide future innovations. Prof. Vlad Ratziu joins the Scientific Advisory Board to strengthen the Company's global scientific leadership in liver disease management. HistoIndex's AI-driven solutions qFibrosis, qSteatosis, and qBallooning can standardize assessments in MASH clinical trials, improving drug...
Ping An Co-CEO Michael Guo at “Summer Davos”: Low Public Awareness of Financial Planning for Senior Care in China is Opportunity for Financial Services Industry
HONG KONG and SHANGHAI, July 1, 2024 /PRNewswire/ -- China's growing senior population is bringing tremendous business opportunities to the financial services industry, says Michael Guo, Co-CEO of Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 2318 / 82318; SSE: 601318). The aging population has low awareness of the need...
Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million
YANGZHOU, China, July 1, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced today that its board of directors (the "Board") has approved and authorized a share repurchase program of up to...
“Twenty Years of Collaboration Leading to New Success” – The 20th Anniversary Press Conference of Medtec China Successfully Held in Shanghai
SHANGHAI, July 1, 2024 /PRNewswire/ -- On the morning of June 26, 2024, the 20th Anniversary Press Conference of Medtec China was successfully held at the Grand Kempinski Hotel Shanghai. Mr. Jack Wei, General Manager of Informa Markets Beijing announced Medtec's new development strategy to establish a " Grid Medical Device Supply Chain Ecosystem". Mr. Linc Cai, Project Director...
IFPA Celebrates Success of the 7th IFPA Conference 2024
STOCKHOLM, July 1, 2024 /PRNewswire/ -- IFPA (The International Federation of Psoriasis Associations) concluded its highly anticipated 7th IFPA Conference on World Psoriasis and Psoriatic Arthritis, held from June 27 to 29, 2024, in Stockholm, Sweden. Established in 2006, the conference has become a cornerstone event for medical and health professionals worldwide,...
IASO Bio Presented Clinical Data and Single-cell Analysis of Equecabtagene Autoleucel for the Treatment of Central Nervous System Autoimmunity in Oral Presentation at EAN Congress 2024
SHANGHAI, NANJING, CHINA, and SAN JOSE, Calif., July 1, 2024 /PRNewswire/ -- IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, presented the clinical data and single-cell analysis of the fully human anti-BCMA CAR T cell therapy (Equecabtagene Autoleucel, Eque-cel) for the treatment of central nervous system autoimmunity in...
National Cancer Society Malaysia and Gene Solutions Forge Partnership to Expand Multi-Cancer Early Detection Awareness and Access
KUALA LUMPUR, Malaysia, July 1, 2024 /PRNewswire/ -- National Cancer Society Malaysia (NCSM) and Gene Solutions are pleased to announce the signing of a Memorandum of Understanding (MOU) to collaborate on expanding awareness and enabling access to multi-cancer early detection (MCED) testing for the Malaysian population. This landmark partnership was inked at the inaugural National Cancer Congress Malaysia 2024...
